Edition:
India

Sanofi India Ltd (SANO.NS)

SANO.NS on National Stock Exchange of India

5,116.95INR
3:29pm IST
Change (% chg)

Rs24.25 (+0.48%)
Prev Close
Rs5,092.70
Open
Rs5,115.00
Day's High
Rs5,199.00
Day's Low
Rs5,100.00
Volume
2,076
Avg. Vol
11,466
52-wk High
Rs5,348.95
52-wk Low
Rs3,940.00

Chart for

About

Sanofi India Limited is an India-based company, which is engaged in the manufacture and sale of pharmaceutical products. The Company provides medicines for the treatment of patients in various therapeutic areas, including cardiology, thrombosis, oncology, diabetes, central nervous system, internal medicine and consumer... (more)

Overall

Beta: 0.13
Market Cap(Mil.): Rs93,862.45
Shares Outstanding(Mil.): 23.03
Dividend: 18.00
Yield (%): 1.67

Financials

  SANO.NS Industry Sector
P/E (TTM): 34.32 30.95 32.75
EPS (TTM): 118.75 -- --
ROI: 13.98 14.84 14.38
ROE: 15.07 16.34 16.07

BRIEF-Sanofi India Gets Shareholders' Nod For Appointment Of Rajaram Narayanan As MD

* GETS SHAREHOLDERS' NOD FOR APPOINTMENT OF RAJARAM NARAYANAN AS MD Source text - https://bit.ly/2I4wGYh Further company coverage:

09 May 2018

BRIEF-Sanofi India March Qtr Profit Rises

* MARCH QUARTER PROFIT 825 MILLION RUPEES VERSUS PROFIT 600 MILLION RUPEES YEAR AGO

08 May 2018

BRIEF-Sanofi India Seeks Shareholders' Nod To Appoint Rajaram Narayanan As MD

* SEEKS SHAREHOLDERS' NOD FOR APPOINTMENT OF RAJARAM NARAYANAN AS MD Source text - http://bit.ly/2qlh9aK Further company coverage:

10 Apr 2018

BRIEF-Sanofi India Dec Qtr Profit Rises

* DEC QTR TOTAL REVENUE FROM OPS 6.70 BLN RUPEES VS 6.05 BLN RUPEES YR AGO Source text - http://bit.ly/2EYEvwc Further company coverage:

22 Feb 2018

BRIEF-Sanofi Launches New Insulin Toujeo In India

* LAUNCHES NEW INSULIN TOUJEOTM IN INDIA Source text - http://bit.ly/2H7ZlXX Further company coverage:

12 Feb 2018

Earnings vs. Estimates